Ilan Ganot - 13 Feb 2024 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot
Issuer symbol
SLDB
Transactions as of
13 Feb 2024
Net transactions value
$0
Form type
4
Filing time
16 Feb 2024, 10:50:46 UTC
Previous filing
30 Jan 2024
Next filing
06 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Restricted Stock Units Award $0 +19,444 $0.000000 19,444 13 Feb 2024 Common Stock 19,444 Wife F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").
F2 The RSUs were granted on the February 13, 2024 and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.